Diagnostic News and Research

RSS
Repligen Corporation completes patient enrollment in RG2417 Phase 2b clinical trial

Repligen Corporation completes patient enrollment in RG2417 Phase 2b clinical trial

Penn Medicine selected as study site for PPMI

Penn Medicine selected as study site for PPMI

Mount Sinai receives contract to develop nanotechnology tools for diagnosing diseases

Mount Sinai receives contract to develop nanotechnology tools for diagnosing diseases

New miRNA screening assay to detect early-stage colorectal cancer

New miRNA screening assay to detect early-stage colorectal cancer

Washington University receives award to develop diagnostic tools for heart, lung diseases using nanotechnology

Washington University receives award to develop diagnostic tools for heart, lung diseases using nanotechnology

COE on Brain Aging at NYU Langone establishes Lewy Body Disease Center

COE on Brain Aging at NYU Langone establishes Lewy Body Disease Center

Circadian partners with Cincinnati Children's Hospital to develop blood test diagnostic for LAM, a serious lung disease

Circadian partners with Cincinnati Children's Hospital to develop blood test diagnostic for LAM, a serious lung disease

Quidel receives FDA clearance for QuickVue RSV 10 immunoassay test

Quidel receives FDA clearance for QuickVue RSV 10 immunoassay test

Sysmex to supply medical hematology analyzers to USAMMA

Sysmex to supply medical hematology analyzers to USAMMA

AACR to host Third Conference on The Science of Cancer Health Disparities

AACR to host Third Conference on The Science of Cancer Health Disparities

Circulating tumor cells may be promising alternative for tumor biopsies

Circulating tumor cells may be promising alternative for tumor biopsies

Scientists develop NIA assay to determine drug's differential effects in tumor cells

Scientists develop NIA assay to determine drug's differential effects in tumor cells

Researchers discover new diagnostic test for prostate cancer

Researchers discover new diagnostic test for prostate cancer

Past malpractice claims help doctors avoid future mistakes

Past malpractice claims help doctors avoid future mistakes

Researchers identify biomarkers for mesothelioma and pancreatic cancer

Researchers identify biomarkers for mesothelioma and pancreatic cancer

Escalon Medical reports 0.2% increase in product revenue for fiscal year 2010

Escalon Medical reports 0.2% increase in product revenue for fiscal year 2010

NCI awards A&G $1.2M Phase II SBIR grant for development of breast cancer drug candidate

NCI awards A&G $1.2M Phase II SBIR grant for development of breast cancer drug candidate

IOF report reveals poor state of post-fracture care in Russian Federation

IOF report reveals poor state of post-fracture care in Russian Federation

Health Council of Canada releases report on how physicians' decisions affect healthcare services in Canada

Health Council of Canada releases report on how physicians' decisions affect healthcare services in Canada

GATC Biotech to apply Illumina's HiSeq 2000 for human genome analysis

GATC Biotech to apply Illumina's HiSeq 2000 for human genome analysis

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.